MDA 2023: COYA 302 therapy slows ALS progression in early trial
Four people with ALS experienced a marked slowing in disease progression after receiving treatment with COYA 302 in a proof-of-concept trial.
0 Comments
MDA 2023: COYA 302 therapy slows ALS progression in early trial
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed